Key research on the prevention, screening and treatment of GI cancers will be the focus of the 2008 Gastrointestinal Cancers Symposium press program. Study authors will discuss notable research in an embargoed presscast (press briefing via live webcast) on January 23 from 1:00 to 2:00 PM (EST).
Featured research includes:
- A study on the association between insurance status and the extent of colorectal cancer spread at the time of diagnosis.
- A study evaluating whether a blood serum-based marker called colon cancer-specific antigen-2 (CCSA-2) can aid in the detection of colorectal cancer.
- A study assessing the benefit of treatment with a monoclonal antibody called panitumumab for colorectal cancer patients based on their tumors’ molecular signatures.
Presscast -- Audio and Slide Presentation
Presscast -- Audio and Slide Presentation (Version for Mac users)
Author Slides
News Releases
Advances in the Treatment of Gastrointestinal Cancers
Young Cancer Doctors to be Recognized for Important Contributions to Gastrointestinal Cancers Research
Fifth Annual Gastrointestinal Cancers Symposium Press Program Announced
Fact Sheets
Gastrointestinal Cancers Fact Sheet
Clinical Trials Fact Sheet
Embargo Policy
Consumer Resources
Cancer Advances: News for Patients from the 2008 Gastrointestinal Cancers Symposium
ASCO Expert Corner: Research Highlights from the 2008 Gastrointestinal Cancers Symposium
PLWC Podcast: 2008 Gastrointestinal Cancers Symposium Highlights with Nicholas Petrelli, MD
ASCO Answers Fact Sheets: Colorectal, esophageal, liver, pancreatic and stomach cancers
ASCO Cancer Treatment Summary: Colorectal cancer
Onsite Press Information
About the Symposium Co-Sponsors
Contact
Danielle Potuto
703-519-1422
potutod@asco.org
|
